Evolution of the Drug Delivery Systems Industry and its Increasing Role in Driving Patient Outcomes
The Drug Delivery Systems (DDS) industry has gone through extensive changes in the last few decades due to its increasing role in driving patient care and outcomes. It has pushed players to develop new strategies that cover the dynamic needs of their biopharmaceutical customers.
Join our guest Amira Ghozali, Director, Strategy and Market Intelligence, Aptar Pharma, Aude Ouensanga, Partner at Alira Health, and our host Kenny Carberry, Associate Director of Clinical Development, Alira Health as they discuss the impact of COVID-19, the evolution of the industry and its future, and the relationship between DDS organizations and the pharma industry by sharing insights and experiences from the perspective of a multinational healthcare consulting firm, and a global manufacturer and supplier of consumer dispensing packaging and drug delivery services.
For recent insights on the Drug Delivery Devices industry, download our latest report here.